| For: | Mok WC, Wasser S, Tan T, Lim SG. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma. World J Gastroenterol 2012; 18(27): 3527-3536 [PMID: 22826617 DOI: 10.3748/wjg.v18.i27.3527] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i27/3527.htm |
| Number | Citing Articles |
| 1 |
. 2018; doi: 10.70675/648777daz9ecfz44abz88cdzcc13fefdb868
|
| 2 |
Peter Dietrich, Kim Freese, Abdo Mahli, Wolfgang Erwin Thasler, Claus Hellerbrand, Anja Katrin Bosserhoff. Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic “dual-hit” option. Oncotarget 2018; 9(3) doi: 10.18632/oncotarget.23188
|
| 3 |
Luc Magloire Anicet Boumba, Clausina Ahoui Mikolele, Dimitri Moudiongui Mboungou Malanda, Ghislain Lobano-Voumbi, Bredin Bissila, Josué Lukera Chimaëlle Biziki Batsimba, Paola Candyse Tsimba, Blaise Irenée Atipo Ibara, Donatien Moukassa. Impact of the Hepatitis B Virus pRE-S2 Mutant on p53 and PLK1 Biomarkers Expression in Patients with Hepatocellular Carcinoma in Brazzaville. Advances in Infectious Diseases 2025; 15(04) doi: 10.4236/aid.2025.154052
|
| 4 |
Shanshan Wu, Hui Wang, Chune Yu, Chen Yang, Xifu Cheng, Long Liao, Ying Cao, Wenxin Qin, Xuhui Ma. Inhibition of Aurora B induces senescence and potentiates immunotherapy in hepatocellular carcinoma. Cellular Oncology 2026; 49(4) doi: 10.1007/s13402-026-01225-2
|
| 5 |
Ya-Hui Huang, Ying-Hsin Tseng, Wey-Ran Lin, George Hung, Tse-Ching Chen, Tong-Hong Wang, Wei-Chen Lee, Chau-Ting Yeh. HBV polymerase overexpression due to large core gene deletion enhances hepatoma cell growth by binding inhibition of microRNA-100. Oncotarget 2016; 7(8) doi: 10.18632/oncotarget.7021
|
| 6 |
Rodrigo F.E. Bogado, Julia A. Pezuk, Harley F. de Oliveira, Luiz G. Tone, María S. Brassesco. BI 6727 and GSK461364 suppress growth and radiosensitize osteosarcoma cells, but show limited cytotoxic effects when combined with conventional treatments. Anti-Cancer Drugs 2015; 26(1) doi: 10.1097/CAD.0000000000000157
|
| 7 |
Jean Baptiste Gossart, Etienne Pascal, Florent Meyer, Emilie Heuillard, Mathieu Gonçalves, Francine Gossé, Eric Robinet, Benoît Frisch, Cendrine Seguin, Guy Zuber. Performance of Pyridylthiourea‐Polyethylenimine Polyplex for siRNA‐Mediated Liver Cancer Therapy in Cell Monolayer, Spheroid, and Tumor Xenograft Models. Global Challenges 2017; 1(4) doi: 10.1002/gch2.201700013
|
| 8 |
Imane El Dika, Ho Yeong Lim, Wei Peng Yong, Chia-Chi Lin, Jung-Hwan Yoon, Manuel Modiano, Bradley Freilich, Hye Jin Choi, Tsu-Yi Chao, Robin K. Kelley, Joanne Brown, Jennifer Knox, Baek-Yeol Ryoo, Thomas Yau, Ghassan K. Abou-Alfa. An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma. The Oncologist 2019; 24(6) doi: 10.1634/theoncologist.2018-0838
|
| 9 |
Xia-Qing Zhou, Ya-Ping Li, Shuang-Suo Dang. Precision targeting in hepatocellular carcinoma: Exploring ligand-receptor mediated nanotherapy. World Journal of Hepatology 2024; 16(2): 164-176 doi: 10.4254/wjh.v16.i2.164
Abstract(764) |
Core Tip(800) |
Full Article(HTML)(3303)
|
Full Article (PDF)-1948K(220)
|
Full Article with Cover (PDF)-2457K(263)
|
Full Article (Word)-656K(150)
|
Full Article (XML)-211K(151)
|
Audio-417K(15)
|
Peer-Review Report-226K(165)
|
Answering Reviewers-105K(181)
|
Times Cited (19)
|
Total Visits (5182)
|
Open
|
| 10 |
Kuo-Shyang Jeng, Chiung-Fang Chang, Wen-Juei Jeng, I-Shyan Sheen, Chi-Juei Jeng. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Critical Reviews in Oncology/Hematology 2015; 94(3) doi: 10.1016/j.critrevonc.2015.01.009
|
| 11 |
Mohan Liu, Yusi Wang, Yibing Zhang, Die Hu, Lin Tang, Bailing Zhou, Li Yang. Landscape of small nucleic acid therapeutics: moving from the bench to the clinic as next-generation medicines. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02112-8
|
| 12 |
Yash Bakane, Ayushi Kar, Masilamani Elizabeth Sobhia. Integrative bioinformatics guided target identification and inhibitor discovery in hepatocellular carcinoma. In Silico Research in Biomedicine 2026; 2 doi: 10.1016/j.insi.2026.100624
|
| 13 |
Zhixian Liu, Qingrong Sun, Xiaosheng Wang. PLK1, A Potential Target for Cancer Therapy. Translational Oncology 2017; 10(1) doi: 10.1016/j.tranon.2016.10.003
|
| 14 |
Sophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, Mulugeta Seneshaw, Divya P. Kumar, Hae-Ki Min, Prasanna K. Santhekadur, Bubu Banini, Adolfo Gabriele Mauro, Abdul M. Oseini, Robert Vincent, Keith Q. Tanis, Andrea L. Webber, Liangsu Wang, Pierre Bedossa, Faridoddin Mirshahi, Arun J. Sanyal. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-17370-6
|
| 15 |
Sara Ortica, Nadine Tarantino, Nathalie Aulner, Alain Israël, Neetu Gupta‐Rossi. The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors. The FASEB Journal 2014; 28(2) doi: 10.1096/fj.13-235903
|
| 16 |
Soham Bhattacharyya, Debopriya Choudhury, Brahmachari Vedeshachaitanya, Pushkar Malakar. Cell Fusion. Advances in Experimental Medicine and Biology 2026; 1509 doi: 10.1007/978-3-032-22637-2_10
|
| 17 |
Zheng Fu, Donghua Wen. The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis. Cancers 2017; 9(10) doi: 10.3390/cancers9100131
|
| 18 |
Michael M.C. Lai, Wen‐Chi Su. Polo‐like‐kinase 1: A key cellular target for anti‐HBV therapy?. Hepatology 2017; 66(6) doi: 10.1002/hep.29407
|
| 19 |
Julia Alejandra Pezuk, María Sol Brassesco, Andressa Gois Morales, Jaqueline Carvalho de Oliveira, Harley Francisco de Oliveira, Carlos Alberto Scrideli, Luiz Gonzaga Tone. Inhibition of Polo-Like Kinase 1 Induces Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Ionizing Radiation. Cancer Biotherapy and Radiopharmaceuticals 2013; 28(7) doi: 10.1089/cbr.2012.1415
|
| 20 |
. 2018; doi: 10.70675/a39d039cz493az49a2z9635z0299397f21de
|
| 21 |
Shufeng Wang, Xinzheng Wang, Xin Yang, Feng Liu, Jin Li, Weihua Li, Zhaofang Bai, Hongbo Wang, Jie Mao, Tingting Li, Kun He, Hongxia Wang. Comprehensive kinomic study via a chemical proteomic approach reveals kinome reprogramming in hepatocellular carcinoma tissues. PROTEOMICS 2022; 22(4) doi: 10.1002/pmic.202100141
|
| 22 |
Yingai Zhang, Shunlan Wang, Jingchuan Xiao, Hailong Zhou. Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma. Bioscience Reports 2019; 39(2) doi: 10.1042/BSR20181845
|
| 23 |
Chelsea E. Cunningham, Mackenzie J. MacAuley, Frederick S. Vizeacoumar, Omar Abuhussein, Andrew Freywald, Franco J. Vizeacoumar. The CINs of Polo-Like Kinase 1 in Cancer. Cancers 2020; 12(10) doi: 10.3390/cancers12102953
|
| 24 |
Ariel Ka-Man Chow, Simon Wing-Lung Yau, Lui Ng. Novel molecular targets in hepatocellular carcinoma. World Journal of Clinical Oncology 2020; 11(8): 589-605 doi: 10.5306/wjco.v11.i8.589
|
| 25 |
Mahmoud A. Younis, Ikramy A. Khalil, Hideyoshi Harashima. Gene Therapy for Hepatocellular Carcinoma: Highlighting the Journey from Theory to Clinical Applications. Advanced Therapeutics 2020; 3(11) doi: 10.1002/adtp.202000087
|
| 26 |
Mahmoud Younis, Hideyoshi Harashima. Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine. Pharmacogenomics and Personalized Medicine 2024; doi: 10.2147/PGPM.S431346
|
| 27 |
Bin Shi, Marc Abrams, Laura Sepp-Lorenzino. Expression of Asialoglycoprotein Receptor 1 in Human Hepatocellular Carcinoma. Journal of Histochemistry & Cytochemistry 2013; 61(12) doi: 10.1369/0022155413503662
|
| 28 |
Hongjun Yu, Chaoqun Wang, Shanjia Ke, Miaoyu Bai, Yanan Xu, Shounan Lu, Zhigang Feng, Baolin Qian, Yue Xu, Menghua Zhou, Zihao Li, Bing Yin, Xinglong Li, Yongliang Hua, Yongzhi Zhou, Shangha Pan, Yao Fu, Yong Ma. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.892750
|
| 29 |
Yeonhwa Song, Su-Yeon Lee, Sanghwa Kim, Inhee Choi, Namjeong Kim, Jongmin Park, Haeng Ran Seo. HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma. Cancers 2023; 15(3) doi: 10.3390/cancers15030851
|
| 30 |
Zewen Song, Zhaomei Yu, Limin Chen, Zhijiao Zhou, Qiong Zou, Yang Liu. MicroRNA-1181 supports the growth of hepatocellular carcinoma by repressing AXIN1. Biomedicine & Pharmacotherapy 2019; 119 doi: 10.1016/j.biopha.2019.109397
|